Aktive Positionen von Michael A. Byrne
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Finanzdirektor/CFO | 01.01.2000 | - |
| Unternehmenssekretär | 01.01.2000 | - |
Karriereverlauf von Michael A. Byrne
Ehemalige bekannte Positionen von Michael A. Byrne
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Hyal Pharmaceutical Corp. | Corporate Officer/Principal | - | - |
Statistik
International
| Kanada | 3 |
Operativ
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
| Hyal Pharmaceutical Corp. | Health Technology |
- Börse
- Insiders
- Michael A. Byrne
- Erfahrung